TobraDex

TobraDex Dosage/Direction for Use

tobramycin + dexamethasone

Manufacturer:

Novartis

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Dosage/Direction for Use
Ophthalmic suspension: Posology: Instil 1 to 2 drops into the conjunctival sac every 4 hours. During the initial 24 to 48 hours the dosage may be increased to 1 or 2 drops every 2 hours. In severe disease, instil 1 or 2 drops every hour until inflammation is controlled, and gradually decrease frequency to 1 to 2 drops every 2 hours during 3 days, and thereafter 1 to 2 drops every 4 hours during 5 to 8 days, and finally 1 to 2 drops every day during the last 5 to 8 days, if necessary.
Care should be taken not to discontinue therapy prematurely.
Gently closing the eyelid and nasolacrimal occlusion after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.
In case of concomitant therapy with other topical ocular medicinal products, an interval of 5 minutes should be allowed between successive applications. Eye ointments should be administered last (see Interactions).
Paediatric population: TOBRADEX eye drops, suspension may be used in children 2 years of age and older at the same dose as in adults. Currently available data is described in Pharmacology: Pharmacodynamics under Actions. The safety and efficacy in children younger than 2 years of age have not been established, and no data are available.
Method of administration: To prevent contamination of the dropper tip and suspension, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use.
After cap is removed, if tamper evident snap collar is loose, remove before using product.
Ophthalmic ointment: Posology: Apply a small amount (1 to 1.5 cm) into the conjunctival sac up to 3 or 4 times daily, or use adjunctively with the eye drops during the day and the eye ointment at bedtime.
Gently closing the eyelid and nasolacrimal occlusion after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.
In case of concomitant therapy with other topical ocular medicinal products, an interval of 5 minutes should be allowed between successive applications. Eye ointments should be administered last (see Interactions).
Paediatric population: TOBRADEX eye ointment may be used in children 2 years of age and older at the same dose as in adults. Currently available data is described in Pharmacology: Pharmacodynamics under Actions. The safety and efficacy in children younger than 2 years of age have not been established, and no data are available.
Method of administration: For ocular use.
To prevent contamination of the tube tip and ointment, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the tube tip. Keep the tube tightly closed when not in use.
1. Tilt the head back.
2. Place a finger on the cheek just below the eye and gently pull down until a "V" pocket is formed between the eye and the lower eyelid.
3. Place a small amount (1 to 1.5 cm) of TOBRADEX eye ointment in the "V" pocket. Do not let the tip of the tube touch the eye.
4. Look downward for a few moments before closing the eye.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in